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Abstract. The purpose of this review is to assess the extent to which dementia 
is omitted as a cause of death from the death certificates of patients with 
dementia. A systematic literature search was performed to identify population-
based cohort studies in which all participants were examined or screened for 
symptoms of dementia with a validated instrument followed by confirmation of 
any suspected cases with a clinical examination (two-phase investigation). Data 
were extracted in a standardized manner and assessed through the 
Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) initiative. Seven studies met the selection criteria. These were from 
America (5 articles, including 2 from Canada, 2 from the United States, and 1 
from Brazil), and Europe (2 articles, including 1 from the United Kingdom, and 1 
from Spain).  Each met at least 83% of the STROBE criteria. The reporting of 
dementia on death certificates was poor in these 7 studies, ranging from 7.2% - 
34%. Respiratory or circulatory-related problems were the most frequently 
reported causes of death among people who were demented but who were not 
reported as demented on death certificates. The use of death certificates for 
studying dementia grossly underestimates the occurrence of dementia in the 
population. The poor reporting of dementia on these certificates suggests a lack 
of awareness of the importance of dementia as a cause of death among 
medical personnel. There is an urgent need to provide better education on the 
importance of codification of dementia on death certificates in order to minimize 






Since the early 12th century, death certificates have been an important 
source of information on population health.[1] Today, nearly 900 years after the 
introduction of the death certificate, death certificate data continue to be 
immensely important in shaping our understanding of the health of a 
population.[1] Death certification, and the specification of the underlying cause 
of death, has been used to map the geographical distribution of multiple 
diseases. For example, dementia has been studied in this way. Death 
certificates have been used as a data source to address both the prevalence 
and incidence of dementia[2] as well as the causes of death associated with 
dementia. In both of these areas, however, the utility of death certificate data 
may be limited.[3] 
 In view of the importance of the subject matter, and the absence of a 
comprehensive review of the validity of death certificates with respect to 
dementia, we undertook a systematic review with the aim to determine the 
extent to which dementia is omitted as a cause of death from the death 
certificate in patients with known dementia.  We included population-based 
cohort studies in which (i) all participants had been examined to detect 
dementia cases or (ii) in which participants had been screened for symptoms of 
dementia with a validated instrument and subsequent confirmation of any 






MATERIAL AND METHODS 
Search Strategy and Information Sources 
 Searches were performed in December 2013 using PUBMED/MEDLINE 
and Google Scholar. The keywords were different combinations of “dementia”, 
“death certificates”, and “Alzheimer’s disease”. In addition, our own extensive 
files were searched. Original articles were obtained, and all reference lists were 
scanned for further relevant articles. No time limit was applied in our search 
strategy. The final list was reviewed by two authors (J.P.R. and J.B.-L.) to 
identify additional studies or unpublished data. 
  
Inclusion and Exclusion Criteria 
We included population-based cohort studies in which (i) all participants 
had been examined to detect dementia cases or (ii) in which participants had 
been screened for symptoms of dementia with a validated instrument and 
subsequent confirmation of any suspected dementia cases with a clinical 
examination (two-phase investigation). We excluded studies based on inpatient 
databases or clinical series. No language restrictions were applied. 
 
Data Extraction 
Two investigators (J.P.R. and J.B.-L.) independently reviewed the title 
and abstract of all citations identified by the initial search and excluded citations 
that clearly did not meet the inclusion criteria. We retrieved the full text of the 
remaining studies and both investigators reviewed each study to assess 
whether it met the inclusion criteria. All differences were settled by discussion. 
For each study, data were abstracted on the design, population size, and 
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clinical diagnostic methods. The outcome of this systematic review was the 
concordance of cause of death codification (as coded on the death certificate) 
with clinical diagnosis of dementia; this concordance was expressed as a 
percentage.  
 The selected articles were also evaluated to assess whether they 
conformed to the Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) recommendations, which seek to assess clarity in the 
description of epidemiological studies.[4] The STROBE includes 22 items that 
are related to the information that must be present in the title, abstract, 
introduction, methods, results, and discussion of scientific articles describing 
observational studies.[4]  
 
Statistical analysis 
 For the evaluation of article selection criteria and study quality among 
reviewers, the kappa-measured agreement was based on the specifications of 
the specialized literature: k < 0.10, no agreement; k < 0.40, weak agreement; 
0.40 < k < 0.75, good agreement; k > 0.75, excellent agreement.[5] 
 
RESULTS 
 The electronic search identified a total of 170 articles, of which 7 articles 
met our inclusion criteria.[6-12] Because the independent selection of articles 
for inclusion in this review showed excellent agreement (k = 0.970), the 
intervention of a third researcher was not required. Figure 1 shows the 




Description of studies 
 The seven articles that met the specific inclusion criteria at the end of the 
selection procedure included five from America (2 from Canada, 2 from the 
United States, and 1 from Brazil), and two from Europe (1 from the United 
Kingdom, and 1 from Spain). The sample size of the studies ranged from 527 to 
10,263 participants. Overall, the reporting of dementia on death certificates in 
these 7 studies was poor, ranging from 7.2 to 34% (Table 1). Four articles 
reported results from two cohorts (the Monongahela Valley Independent Elders 
Survey [MoVIES] and the Canadian Study of Health and Aging).[7-10] Table 1 
summarizes the diagnostic criteria used for dementia as well as the causes of 
death among those who were demented but who were not reported as 
demented on death certificates. Respiratory or circulatory-related problems 
were the most frequently reported causes of death in these people.  
 Of 1,042 elderly people, randomly selected by Morgan and Clarke,[6] 
there were 512 deaths in the period from 1985–1994, with 44 of these deaths 
occurring among respondents who, at clinical interview, met Diagnostic and 
Statistical Manual of Mental Disorders, 3rd Edition—Revised (DSM-III-R) criteria 
for dementia.[13] The presence of dementia, however, was recorded on only 15 
(34%) of the 44 death certificates.[6] This low level of recording was not 
significantly related to the patient's gender, age, or place of death (i.e., at a 
private home vs. at an institution). Also, earlier (1985–1990) and later (1990–
1994) certificates showed similar levels of non-recording.[6]  
 Ganguli and Rodríguez[9] used a prospective epidemiological study in 
which community-dwelling elderly subjects with and without dementia (N = 
1,422, the MoVIES study) were identified and followed until death, after which 
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their death certificates were examined.[9] The cohort was established between 
1987 and 1989, and mortality data were reported as of December 31, 1996.[9] 
Death certificates were examined for a total of 527 deceased participants, 
including 172 individuals to whom research diagnoses of dementia had been 
assigned during life applying DSM-III-R criteria.[9] Of these 172 deceased 
subjects, conditions indicating or suggesting dementia were reported in 23.8% 
of death certificates.[9] In a multiple logistic regression model, variables 
associated independently with the reporting of dementia in demented 
individuals were: greater severity of dementia, likely etiology of dementia 
(probable Alzheimer’s disease more frequently reported), and dying in a long-
term care institution.[9]  
 Østbye et al.[7], using data from the Canadian Study of Health and 
Aging, compared 5-year overall mortality and causes of death in elderly with 
and without dementia. The cohort consisted of 2,923 people who underwent a 
clinical examination and 7,340 people who screened negative for cognitive 
impairment and did not undergo a clinical examination.[7] Among patients 
clinically diagnosed with Alzheimer’s disease, only 14.3% had any dementing 
illness recorded as the underlying cause of death; 41.8% had any dementing 
illness recorded anywhere on the death certificate.[7] For vascular dementia, 
the corresponding numbers were 5.8% and 23.3%.[7]  
 Chamandy and Wolfson [10] also examined the associations between 
clinical dementia and underlying cause of death in the Canadian Study of 
Health and Aging. However, the methods were slightly different from the paper 
by Østbye et al.[7] who previously examined cause of death in the cohort, but in 
the context of a larger analysis and a coarser partition of causes of death (e.g., 
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pneumonia was not differentiated from chronic respiratory conditions). Cause-of 
death data were obtained via death certificates for 2,924 of 2,982 deceased 
subjects. Among 754 demented, 7.2% were coded as Alzheimer’s disease in 
death certificates.[10] 
 Ganguli et al.,[8] examined mortality rates, duration of survival, causes of 
death, and the contribution of Alzheimer’s disease to the risk of mortality in the 
MoVIES study, a community-based cohort of 1,670 elderly adults (1,422 
randomly selected from voter registration lists and an additional 259 volunteers 
from the same area).[8] Mortality data were reported as of December 31, 2002. 
Only 29 (12.3%) of the 236 participants with Alzheimer’s disease had this 
condition reported in their death certificate.[8] 
 Nitrini et al.,[11] studied a cohort of 1,656 elderly individuals who were 
screened for dementia at their homes in 1997. The same population was re-
evaluated in 2000, and information on deaths was obtained from relatives and 
from the municipal obituary service.[11] As of 1997, the number of deaths was 
58 (51.3%) among the patients with dementia and 163 (12.7%) among those 
without dementia. Dementia and/or Alzheimer’s disease were mentioned in only 
12.5% of the death certificates of individuals with dementia.[11] 
 Finally, Romero at al.,[12] in a prospective population-based study 
(NEDICES), using a two-phase approach involving 4,197 community-dwelling 
elderly subjects with and without dementia followed during a median of 12.5 
years, examined the death certificates of those who died (1,976 [47.1%], 
including 403 subjects with dementia). Dementia was rarely reported as the 
primary cause of death, even in known cases of dementia (20.8%).[12] 
Specifically, it was reported in only 13.3% of those with mild dementia and 
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24.3% of those with moderate or severe dementia; in 24.9% of those with 
possible or probable Alzheimer's disease; and in 11.9% of those with non-
Alzheimer dementia.[12] In a stepwise multiple logistic regression analysis with 
the dependent variable being presence or absence of dementia on the death 
certificate, age at death, severity of dementia, and etiology of dementia were 
the significantly associated independent variables.[12] 
 
Quality of studies  
 The evaluation of agreement between the evaluators (J.P.R. and J.B.-L.) 
in the classification of articles, according to the STROBE criteria showed 
excellent agreement (k = 0.758). All articles met at least 83% of the STROBE 
criteria (Table 2). All of them stated the specific objectives. In addition, the key 
elements of the study design and main results were presented in all seven 












In this review of population-based studies published up to December 
2013 in PubMed/Medline and Google Scholar databases, we tried to elucidate 
the extent to which dementia is omitted as a cause of death from death 
certificates. We restricted our analysis to population-based cohort studies in 
which all participants were examined or in which all participants were screened 
for symptoms of dementia with a validated instrument followed by a 
confirmation of any suspected cases with a clinical examination (two-phase 
investigation). We focused on these types of studies because, unlike clinical 
series or hospital registries, these tended to include even those with previously 
undiagnosed dementia residing in the population. 
Our conclusions are as follows. First, there are very few studies (seven in 
total) meeting these criteria. Second, all studies we included met the majority of 
required items from the STROBE guidelines. Finally, dementia was reported in 
fewer than one third of the deaths of community-dwelling demented individuals. 
Three of the studies assessed whether a broad range of variables was 
correlated with the reporting of dementia on death certificates.[6, 9, 12] 
Dementia was significantly more likely to be reported in more advanced 
dementia, those with probable Alzheimer’s disease, younger patients, and those 
who die in nursing homes. However, gender does not appear to influence this 
reporting. In a British series of death certificates of early onset-cases from 
hospital-case records, Newens et al.,[14] found that dementia was more likely to 
be underreported in men; by contrast, in other clinical series, such as CERAD, 
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dementia was significantly less likely to be certified in women who had been 
diagnosed as having Alzheimer’s disease.[15] 
With respect to age at death, the results are not consistent. In the 
NEDICES study, among those died before 85 years, compared to those aged 
85 and over, the odds that dementia was reported on death certificates was 
2.33, 95%, confidence interval (1.33–4.10), p = 0.003. This suggests that 
physicians may consider cognitive disorders to be a function of normal ageing 
and not diagnose dementia in their oldest patients. In CERAD, age at death was 
not related to under reporting of dementia on death certificates.[15]   
All of the included cohorts were ethnically homogeneous.[6-12] This did 
not allow us to analyse the impact of race on reporting; however, in clinical 
series, dementia was significantly less likely to be certified in blacks.[15]  
Dementia seems more likely to be listed on death certificates of 
individuals who had been clinically diagnosed with Alzheimer’s  disease or 
probable Alzheimer’s  disease than those diagnosed as other non- Alzheimer’s  
disease dementias.[9, 12] This is in line with the results from other dementia 
registries.[16-18] This may reflect a lack of recognition of dementia in the 
context of stroke or a displacement of dementia from the death certificate by the 
underlying vascular causes of both death and dementia, mainly cerebrovascular 
diseases. With respect to severity of dementia, higher severity of dementia was 
associated with higher odds of reporting dementia in the death certificates,[9, 
12] similar to clinical series.[19] The certifying physician might be less likely to 
have documented dementia when the disorder is mild.[14] In other words, mild 
dementia may be less likely to be listed on death certificates because its 
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presence is less evident to the certifying physician. It is widely known that 
severe dementia increases the mortality risk through immobility, swallowing 
disorders, incontinence, and malnutrition.[9, 20] However, physicians may not 
report dementia, even when they are aware of the severity of dementia, if they 
do not feel to be underlying or contributing to the patient's death.[9] The 
aforementioned complications of severe dementia, in turn, underlie more 
immediate causes of death, including pneumonia.[10, 16, 18, 21] Further, 
common comorbid disorders in the elderly, such as heart disease, stroke, hip 
fractures, and chronic obstructive lung disease are in general better accepted 
as causes of death. In other reported conditions, such as Parkinson's disease, 
cognitive problems, including dementia, are often observed.[22, 23] If death 
certificates data are to be used to estimate mortality from dementing disorders, 
it may be useful to simultaneously search for documentation of other reported 
central nervous system conditions likely to be associated with dementia.[9] 
Dementia is more often reported for the demented who die in psychiatric 
and geriatric facilities.[9] It seems logical that nursing homes have more 
patients with more severe and full-blown dementia and therefore physicians 
attending those centers are more likely to report dementia on death 
certificates.[24] 
Although regional or national differences in diagnostic accuracy of 
conditions reported on death certificates have been suggested, with European 
rates higher than rates in the USA,[16, 18, 21] the rates of the present review 
are similar. Thus, in the MoVIES study, conducted in the USA, conditions 
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indicating or suggesting dementia was reported in 23.8% of death certificates 
vs. 20.8% in the Spanish NEDICES study.[9, 12] 
In the last years, dementia awareness has increased among both 
physicians and the public, in general. Previous surveys have found that the 
frequency with which dementia was recorded on death certificates increased 
significantly over the years of their study.[14, 15] However, the period during 
which death certificates were completed did not influence the rate of reporting in 
the MoVIES and NEDICES studies,[9, 12] or in  Morgan and Clarke’s study,[6].  
Increased awareness of medical staff regarding the mortality and 
morbidity associated with dementia could lessen the degree of under reporting. 
For example, in the CERAD study, in the first wave, only 49% endorsed 
dementia versus 65% in the second wave (p < 0.025),[15] suggesting that 
greater awareness among the medical staff could result in increased coding of 
dementia as a cause of death. Of interest, none of the studies assessed who 
signed the death certificate (i.e., general physician versus neurologist or 
geriatrician). It is logical to assume that the level of expertise of the physician 
who signed the death certificate might predict the level of accuracy of that 
certificate.  
 This study had potential limitations. Database restriction and the search 
strategy may have excluded important studies that were not published in the 
data sources we searched, although we used multiple overlapping study 
identification methods, so this is not likely. 
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 In closing, the use of death certificates for studying dementia grossly 
underestimates the occurrence of dementia in the population. The poor 
reporting of dementia on these certificates suggests a lack of awareness of the 
importance of dementia as a cause of death among medical personnel. There is 
an urgent need to provide better education on the importance of codification of 
dementia on death certificates in order to minimize errors in epidemiological 
studies on dementia. 
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Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition—Revised (DSM-III-R) 
 





Reference Diagnostic criteria 
for dementia 
Reporting of dementia 
on death certificates 
Causes of death in those who were demented but who were not reported 
as demented on death certificates 
Morgan and 
Clarke., 1995 
DSM-III-R 34% (as an associated 
underlying condition) 
Broncho-pneumonia (72.1%); cerebrovascular disease (11.6%); heart disease 
(9.1%); cancer (4.6%); sepsis (2.3%) 
 Ganguli and 
Rodríguez., 1999 
DSM-III-R  23.8% Not reported 
Østbye et al., 1999 DSM-III-R  41.8% of  Alzheimer’s 
disease  patients. 
23.3% of vascular 
dementia patients 
Most deaths in people with dementia were due to diseases of the respiratory or 








Ischemic heart disease (19.2%); other heart/circulatory system disease 
(13.3%); cerebrovascular disease (13.1%); pneumonia (12.3%); cancer 
(10.7%); chronic respiratory disease (4.2%) 
Ganguli et al., 2005 DSM-III-R  12.3% of Alzheimer’s 
disease patients 
Cardiovascular (47.5%); respiratory (22.5%); cancer (12.3%); other brain 
disorder (5.5%); genitourinary (5.5%); gastrointestinal (4.7%); unknown “natural 
causes” (2.1%); miscellaneous (10.2%) 
Nitrini et al., 2005 DSM-IV 12.5% Pneumonia (40.0%); respiratory failure (27.5%); heart failure (20.0%); sepsis 
(20.0%); stroke (20.0%); cancer (17.5%); cardiorespiratory arrest (15%); renal 
failure (12.5%); arrhythmia (10%); pulmonary embolism (7.5%); acute 
myocardial infarction (5.0%); coronary artery disease (5.0%) 
Romero et al., 
2013 
DSM-IV 20.8% Cerebrovascular disorders (13.4%); cardiovascular diseases (27.5%); 
respiratory diseases (14.4%); cancer (6.0%); other causes (17.9%) 
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Table 2: Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) recommendations and reported 






































































































































































 Title and abstract (a) Indicate the study’s design with a commonly used term in the title 
or the abstract 
X X X X X X X 7/7(100%) 
(b) Provide in the abstract an informative and balanced summary of 
what was done and what was found 
X X X X X X X 7/7(100%) 
Introduction Background/rationale Explain the scientific background and rationale for the investigation 
being reported 
X X X X X X X 7/7(100%) 
Objectives State specific objectives, including any prespecified hypotheses X X X X X X X 7/7(100%) 
Methods Study design Present key elements of study design early in the paper X X X X X X X 7/7(100%) 
Setting Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection 
X X X X X X X 7/7(100%) 
Participants Give the eligibility criteria, and the sources and methods of selection of 
participants. Describe methods of follow-up 
X X X X X X X 7/7(100%) 
Variables Clearly define all outcomes, exposures, predictors, potential 
confounders, and effect modifiers. Give diagnostic criteria, if applicable 
X X X X X X X 7/7(100%) 
Data sources/ 
measurement 
 For each variable of interest, give sources of data and details of 
methods of assessment (measurement). Describe comparability of 
assessment methods if there is more than one group 
X X X X X X X 7/7(100%) 
Bias Describe any efforts to address potential sources of bias X X X X X X X 7/7(100%) 
Study size Explain how the study size was arrived at X X X X X X X 7/7(100%) 
Quantitative variables Explain how quantitative variables were handled in the analyses. If 
applicable, describe which groupings were chosen and why 
X X X X X X X 7/7(100%) 
Statistical methods (a) Describe all statistical methods, including those used to control for 
confounding 
X X X X X X X 7/7(100%) 
(b) Describe any methods used to examine subgroups and interactions X X X X X X X 7/7(100%) 
(c) Explain how missing data were addressed X X X X X X X 7/7(100%) 
(d) If applicable, explain how loss to follow-up was addressed X X X X X X X 7/7(100%) 
Results Participants (a) Report numbers of individuals at each stage of study—e.g. 
numbers potentially eligible, examined for eligibility, confirmed eligible, 












included in the study, completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 0 0 0 0 0 0 0 0/7 (0%) 
(c) Consider use of a flow diagram 0 0 0 X 0 0 X 2/7(28.5%) 
Descriptive data (a) Give characteristics of study participants (e.g. demographic, 
clinical, social) and information on exposures and potential 
confounders 
0 0 0 X 0 X X 3/7(42.8%) 
(b) Indicate number of participants with missing data for each variable 
of interest 
0 0 0 0 0 0 0 0/7 (0%) 
(c) Summarise follow-up time (e.g., average and total amount) X X X X X X X 7/7(100%) 
Outcome data Report numbers of outcome events or summary measures over time X X X X X X X 7/7(100%) 
Main results  Give unadjusted estimates and, if applicable, confounder-adjusted 
estimates and their precision (e.g., 95% confidence interval). Make 
clear which confounders were adjusted for and why they were included 
X X X X X X X 7/7(100%) 
Other analyses Report other analyses done—e.g. analyses of subgroups and 
interactions, and sensitivity analyses 
0 X X X X X X 6/7(85.7%) 
Discussion Key results Summarise key results with reference to study objectives X X X X X X X 7/7(100%) 
Limitations Discuss limitations of the study, taking into account sources of 
potential bias or imprecision. Discuss both direction and magnitude of 
any potential bias 
X 0 0 X 0 X X 4/7(57.1%) 
Interpretation Give a cautious overall interpretation of results considering objectives, 
limitations, multiplicity of analyses, results from similar studies, and 
other relevant evidence 
X X X X X X X 7/7(100%) 
Generalizability Discuss the generalizability (external validity) of the study results X X X X X X X 7/7(100%) 
Other 
Information 
Funding Give the source of funding and the role of the funders for the present 
study and, if applicable, for the original study on which the present 
article is based 
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Figure 1: Identification of studies in the systematic review. 
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